To investigate the cell signaling status of various direct and indirect targets of erlotinib and metformin in BBCs, we examined the phosphorylation levels of EGFR, AMPK, AKT, S6 and 4E-binding protein 1 (4EBP1) in a panel of breast cancer cell lines. Here, EIF4EBP1 is linked to breast cancer.